8-K: Avinger Inc. Receives Nasdaq Non-Compliance Notice Due to Low Share Price

Avinger, Inc. has been notified by Nasdaq that it is not in compliance with listing rules due to its stock price falling below $1 for an extended period.

Summary

• Avinger, Inc. received a notification from Nasdaq on November 20, 2024, stating that the company is not compliant with Nasdaq Listing Rule 5550(a)(2).
• The non-compliance is due to the company's stock price trading below $1 for 32 consecutive business days.
• Avinger has 180 calendar days, until May 19, 2025, to regain compliance by having its stock price close at or above $1 for at least ten consecutive business days.
• If the company fails to regain compliance within the initial 180-day period, it may be eligible for an additional 180 days if it meets certain other listing requirements and provides notice of its intention to cure the deficiency.
• The company is actively monitoring its stock price and will consider options to regain compliance, including a potential reverse stock split.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the non-compliance notice and the risk of delisting, although the company has time to rectify the situation.

Positives

• The notice has no immediate impact on the listing of Avinger's securities on Nasdaq.
• Avinger has a 180-day period to regain compliance, providing time to address the issue.
• There is a possibility of an additional 180-day extension if certain conditions are met.

Negatives

• Avinger's stock price has fallen below the minimum bid price requirement of $1 for 32 consecutive business days.
• The company is at risk of being delisted from Nasdaq if it fails to regain compliance within the given timeframes.
• The need to consider a reverse stock split indicates a significant challenge in maintaining the required share price.

Risks

• Failure to regain compliance with Nasdaq listing rules could lead to the delisting of Avinger's stock.
• A reverse stock split, while a potential solution, could negatively impact investor sentiment.
• The company's ability to raise capital may be hindered if it is delisted or perceived as being at risk of delisting.

Future Outlook

Avinger intends to actively monitor its bid price and consider available options to resolve the deficiency and regain compliance with the Nasdaq Listing Rules.

Management Comments

• The company intends to actively monitor its bid price and will consider available options to resolve the deficiency and regain compliance with the Nasdaq Listing Rules.

Industry Context

This announcement is not uncommon for companies facing financial challenges, and it highlights the importance of maintaining a minimum share price to remain listed on major exchanges like Nasdaq. Other companies in the medical device sector may face similar challenges if their stock price declines significantly.

Comparison to Industry Standards

• Many small-cap medical device companies face similar challenges with maintaining share price compliance on major exchanges.
• Companies like Avinger often need to implement strategies such as reverse stock splits or capital raises to regain compliance.
• Other companies that have faced similar delisting notices include those with limited revenue or those that have experienced significant market downturns.

Stakeholder Impact

• Shareholders may experience a decline in the value of their investment if the company is delisted.
• Employees may face uncertainty about the company's future.
• Creditors may be concerned about the company's ability to meet its obligations.

Next Steps

• Avinger will actively monitor its bid price.
• Avinger will consider available options to resolve the deficiency.
• Avinger will attempt to regain compliance with the Nasdaq Listing Rules.

Key Dates

Keywords

Nasdaq, delisting, non-compliance, minimum bid price, stock price, reverse stock split, listing rule, AVGR